| 1 |
26687796 | (90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study. | 2015 Mar |
2 |
| 2 |
25150258 | Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphoma. | 2014 Nov |
2 |
| 3 |
23927500 | BCR-ABL1 molecular remission after 90Y-epratuzumab tetraxetan radioimmunotherapy in CD22+ Ph+ B-ALL: proof of principle. | 2013 Dec |
3 |
| 4 |
21658624 | Radioimmunotherapy in follicular lymphoma. | 2011 Jun |
1 |